000			01263cam a22003494a 4500
001			12295059
003			BD-DhUL
005			20150308110041.0
008			010131s2001 enka b 001 0 eng c
010			_a 2001016816
020			_a1574911201
035			_a(DNLM)101086595
040			_aDNLM/DLC _cDLC _dDLC _dBD-DhUL
042			_apcc
050	0	0	_aRS200 _b.P425 2001
060	1	0	_aQV 778 _bP53535 2001
082	0	0	_a615.19 _221 _bPHA
245	0	0	_aPharmaceutical preformulation and formulation : _ba practical guide from candidate drug selection to commercial dosage form / _cedited by Mark Gibson
260			_aLondon : _bTaylor & Francis, _cc2001.
300			_axi, 596 p. : _bill. ; _c26 cm.
504			_aIncludes bibliographical references and index.
650		0	_aDrugs _xDosage forms.
650	1	2	_aDrug Compounding.
650	2	2	_aBiopharmaceutics _xmethods.
650	2	2	_aChemistry, Pharmaceutical _xmethods.
650	2	2	_aDosage Forms.
650	2	2	_aDrug Evaluation.
700	1		_aGibson, Mark _d1957-
942			_2ddc _cBK
955			_ato NLM pc14 01-31-01; yk05 to ASCD 02-07-01; jc02 to technician 02-08-01; jc13 02-08-01; to Dewey 02-08-01;aa03 2-9-01 _aps09 2001-09-14 bk rec'd, to CIP ver.
955			_aDEOF fixed; ta00 2002-06-06
999			_c34638 _d34638